Insider Stock Trading History of Cassella James V


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cassella James V since year 2005. The trader's CIK number is 1353528. At the time of this reporting, Cassella James V is the Chief Development Officer of Concert Pharmaceuticals, Inc. . (stock ticker symbol CNCE). See this page for all insider trading activities at Concert Pharmaceuticals, Inc. .

Note that in the past Cassella James V also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Cassella James V since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-04-17 CNCE Concert Pharmaceuticals, Inc. Sale 10,582 20.18 213,513
2012-12-26 ALXA Alexza Pharmaceuticals Inc. Sale 4,558 4.90 22,315
2012-08-27 ALXA Alexza Pharmaceuticals Inc. Sale 10,000 4.14 41,360
2012-06-06 ALXA Alexza Pharmaceuticals Inc. Sale 46,222 .34 15,623
2009-12-18 ALXA Alexza Pharmaceuticals Inc. Sale 12,408 2.13 26,391
2009-12-17 ALXA Alexza Pharmaceuticals Inc. Sale 4,284 2.20 9,429
2009-12-16 ALXA Alexza Pharmaceuticals Inc. Sale 7,732 2.41 18,610

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cassella James V (Chief Development Officer of Concert Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.